{
    "SLCO2B1": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": 0.00975
            },
            {
                "Organ": "Kidney",
                "Source": "Nishimura",
                "Relative Expression": 0.0262
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": 0.0677
            },
            {
                "Organ": "Placenta*",
                "Source": "Nishimura",
                "Relative Expression": 0.0557
            },
            {
                "Organ": "Small Intestine*",
                "Source": "Nishimura",
                "Relative Expression": 0.0277
            },
            {
                "Organ": "Kidney",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 6.496
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 65.867
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Atorvastatin",
                "IC50 (μM)": 0.4,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Grube, 2006"
            },
            {
                "Inhibitor": "Bromsulphthalein (BSP)",
                "IC50 (μM)": 2.0,
                "Ki (μM)": 1.5,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Bromsulphthalein (BSP)",
                "IC50 (μM)": 1.7,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "COS1-OATP2B1",
                "Reference": "Lan, 2009"
            },
            {
                "Inhibitor": "Cerivastatin",
                "IC50 (μM)": 66.2,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Grube, 2006"
            },
            {
                "Inhibitor": "Cyclosporine*",
                "IC50 (μM)": 20.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Cyclosporine*",
                "IC50 (μM)": 0.07,
                "Ki (μM)": null,
                "Substrate used": "Rosuvastatin",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Ho, 2006"
            },
            {
                "Inhibitor": "Estrone",
                "IC50 (μM)": 2.5,
                "Ki (μM)": 1.9,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Gemfibrozil",
                "IC50 (μM)": 8.0,
                "Ki (μM)": null,
                "Substrate used": "Rosuvastatin",
                "Cell System": "HeLa-OATP2B1",
                "Reference": "Ho, 2006"
            },
            {
                "Inhibitor": "Indinavir",
                "IC50 (μM)": 3.9,
                "Ki (μM)": 3.0,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 0.2,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Montelukast",
                "IC50 (μM)": 1.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Paclitaxel",
                "IC50 (μM)": 25.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Repaglinide",
                "IC50 (μM)": 5.2,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Bachmakov, 2008"
            },
            {
                "Inhibitor": "Rifampicin",
                "IC50 (μM)": 90.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Rifampicin",
                "IC50 (μM)": 2.1,
                "Ki (μM)": 1.6,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Rifamycin SV",
                "IC50 (μM)": null,
                "Ki (μM)": 3.0,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "OATP2B1-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Inhibitor": "Rifamycin SV",
                "IC50 (μM)": 3.0,
                "Ki (μM)": 2.3,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Ritonavir",
                "IC50 (μM)": 6.3,
                "Ki (μM)": 4.8,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Rosiglitazone",
                "IC50 (μM)": 5.2,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Bachmakov, 2008"
            },
            {
                "Inhibitor": "Saquinavir",
                "IC50 (μM)": 5.3,
                "Ki (μM)": 4.0,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "Caco-2",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Silibinin dihemisuccinate",
                "IC50 (μM)": 1.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Simvastatin",
                "IC50 (μM)": 84.7,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Grube, 2006"
            }
        ],
        "substrates": [
            {
                "Substrate": "Atorvastatin",
                "Km (μM)": "0.2",
                "Cell System": "MDCK II-OATP2B1",
                "Reference": "Grube, 2006"
            },
            {
                "Substrate": "Bosentan",
                "Km (μM)": "202",
                "Cell System": "CHO-OATP2B1",
                "Reference": "Treiber, 2007"
            },
            {
                "Substrate": "Bromsulphthalein (BSP)",
                "Km (μM)": "0.7",
                "Cell System": "OATP2B1-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "6.3",
                "Cell System": "OATP2B1-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "7.14",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Satoh, 2005"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "8.09",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Nozawa, 2004"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "10.2",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Noe, 2007"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "20.9",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Hirano, 2006"
            },
            {
                "Substrate": "Fexofenadine",
                "Km (μM)": "ND",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Nozawa, 2004"
            },
            {
                "Substrate": "Fluvastatin",
                "Km (μM)": "0.75",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Noe, 2007"
            },
            {
                "Substrate": "Glyburide",
                "Km (μM)": "6.26",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Satoh, 2005"
            },
            {
                "Substrate": "Pitavastatin",
                "Km (μM)": "1.17",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Hirano, 2006"
            },
            {
                "Substrate": "Pravastatin",
                "Km (μM)": "2250",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Nozawa, 2004"
            },
            {
                "Substrate": "Rosuvastatin",
                "Km (μM)": "2.4",
                "Cell System": "HeLa-OATP2B1",
                "Reference": "Ho, 2006"
            },
            {
                "Substrate": "Rosuvastatin",
                "Km (μM)": "6.42",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Kitamura, 2008"
            },
            {
                "Substrate": "Taurocholate*",
                "Km (μM)": "71.8",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Nozawa, 2004"
            },
            {
                "Substrate": "Telmisartan glucuronide",
                "Km (μM)": "1.09",
                "Cell System": "HEK293-OATP2B1",
                "Reference": "Ishiguro, 2008"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Atazanavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "3.1",
                "Cmax": "7.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Busti, 2008",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Docetaxel",
                "AUC": "7.3",
                "Cmax": "5.7",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Malingre, 2001",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Paclitaxel",
                "AUC": "8.5",
                "Cmax": "2.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Meerum, 1999",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Pitavastatin",
                "AUC": "4.6",
                "Cmax": "6.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Livalo Drug Label",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "5.0",
                "Cmax": "10.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "6.4",
                "Cmax": "18.2",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Erythromycin",
                "Affected Drug": "Simvastatin",
                "AUC": "6.2",
                "Cmax": "3.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Indinavir  / Ritonavir",
                "Affected Drug": "Fexofenadine",
                "AUC": "4.8",
                "Cmax": "2.5",
                "CLR": "ND",
                "CL/F": "0.2",
                "t1/2": "0.7",
                "Effect on PD": "ND",
                "Reference": "Kharasch, 2009",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Lopinavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "2.1",
                "Cmax": "4.7",
                "CLR": "ND",
                "CL/F": "0.5",
                "t1/2": "NS",
                "Effect on PD": "yes",
                "Reference": "Kiser, 2008",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Rifampicin",
                "Affected Drug": "Glyburide",
                "AUC": "2.2",
                "Cmax": "1.8",
                "CLR": "NS",
                "CL/F": "0.5",
                "t1/2": "ND",
                "Effect on PD": "yes",
                "Reference": "Zheng, 2009",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Digoxin",
                "AUC": "1.9",
                "Cmax": "ND",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "2.6",
                "Effect on PD": "ND",
                "Reference": "Ding, 2004",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Saquinavir",
                "AUC": "29.9",
                "Cmax": "22.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "la, 2007",
                "More Details": "DDI 12"
            },
            {
                "DDI": "13",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Verapamil",
                "Affected Drug": "Simvastatin",
                "AUC": "4.6",
                "Cmax": "2.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 13"
            }
        ]
    }
}